Centrioles are essential for the assembly of both centrosomes and cilia. Centriole biogenesis occurs once and only once per cell cycle and is temporally coordinated with cell-cycle progression, ensuring the formation of the right number of centrioles at the right time.
In Brief
Zitouni, Francia et al. explore the mechanisms coupling the cell cycle to centrosome biogenesis, and show that in mitosis, CDK1 competes with PLK4, the trigger of centriole biogenesis, for binding to its substrate STIL. PLK4 binding and phosphorylation of STIL occurs only upon CDK1 activity drop at mitotic exit, leading to centriole biogenesis onset.
INTRODUCTION
Centrosomes are the main microtubule-organizing centers (MTOCs) of mammalian cells [1] , composed of two centrioles.
These are surrounded by the pericentriolar material, which nucleates microtubules and organizes the cytoskeleton. Centrioles can also nucleate the ciliary axoneme. Centriole number is highly controlled in cells; abnormalities can lead to defects in spindle and cilium assembly [1] . A new (daughter) centriole normally forms in physical proximity to a pre-existing (mother) centriole; this occurs once and only once per cell cycle (centriole-guided assembly). When no pre-existing centrioles are found in a cell, centrioles can also form ''de novo,'' and in this case they form in random numbers [1] . Interestingly, the timing of centriole biogenesis is conserved in both; new centrioles only form in S phase [2] .
Both centriole-guided and de novo biogenesis are dependent on and initiated by Polo-like kinase 4 (PLK4) [3] [4] [5] . In the case of centriole-guided biogenesis, PLK4 is recruited to the proximal end of the mother centriole, determining the place of biogenesis [6] . PLK4 binds and phosphorylates STIL (SCL/TAL1/SAS5/ Ana2), recruiting it to the centriole [7] [8] [9] [10] [11] . Phosphorylated STIL in turn brings SAS6 to the centrioles to form the centriole cartwheel [7, 8] , the first visible structure in centriole assembly that helps in defining the centriolar 9-fold symmetry [12] . Overexpression or stabilization of PLK4, STIL, or SAS6 leads to supernumerary centrioles, whereas their individual depletion blocks centriole duplication [3, 12] .
Centriole biogenesis is tightly coupled to cell-cycle progression. The formation of the cartwheel is detectable early in S phase, concomitant with the start of DNA replication [1, 13] . Paradoxically, PLK4, STIL, and SAS6 are present at the centrosome in mid-G1 up until the end of mitosis [9, [14] [15] [16] . The physical proximity between mother and daughter centriole is thought to prevent formation of yet another daughter centriole in S, G2, and mitosis [1, 17] . However, already in a natural or arrested prophase and prometaphase, mother and daughter centriole reach a critical distance from each other shown to be permissive for centriole reduplication, yet they do not reduplicate at that stage [18] [19] [20] . Moreover, it has been shown in both Drosophila and Xenopus egg extracts that although PLK4 can induce de novo MTOC formation upon meiosis exit, it cannot do it in meiosisarrested eggs or extracts [21, 22] . Together, these facts suggest the existence of additional levels of regulation during high CDK1-CyclinB activity phases, such as mitosis and meiosis.
Here we explore the mechanism that couples cell-cycle progression to the first molecular events in centriole biogenesis: PLK4-STIL complex formation and STIL phosphorylation. We show that CDK1-CyclinB prevents precocious PLK4-STIL complex assembly and STIL phosphorylation by PLK4, through direct binding to STIL. Upon mitotic exit and consequent CDK1-CyclinB degradation, PLK4 can bind and phosphorylate STIL, which recruits SAS6.
RESULTS
We first asked when the activity of the trigger of centriole biogenesis, PLK4, is required. We used Xenopus egg extracts, which allow tight cell-cycle synchrony and are naturally acentriolar, and therefore are uniquely suited to investigate the biochemical regulation of de novo centriole biogenesis in the absence of physical constraints imposed by the close proximity of the mother centriole. Endogenous Xenopus PLK4 (PLX4) is not detectable in extracts and not sufficient to generate MTOCs de novo, presumably due to low expression levels of this kinase [23] . However, overexpression of PLX4 is sufficient to induce de novo assembly of g-tubulin-containing MTOCs [22] , offering an assay to understand the biochemical connection between the cell cycle and PLK4's role in MTOC formation.
PLK4 Can Only Trigger De Novo MTOC Formation after Exit from M Phase
We used the well-characterized cytostatic factor (CSF) extract, which is prepared from Xenopus eggs arrested at the second meiotic metaphase (MII) by the CSF. This extract allows the sequential study of three different biochemical states. The first is the CSF-arrested state ( Figure 1A ) (from here on referred to as ''M phase''), which has high CDK1-CyclinB activity. The second is a CSF exit/M exit state, which normally commences following fertilization but can be artificially induced through the addition of Ca 2+ to the M phase extract [24] . The addition of Ca 2+ inactivates the CSF, followed by cyclin degradation by the anaphase-promoting complex (APC/C) and dephosphorylation of CDK1-CyclinB substrates, such as Cdc25 ( Figure 1A ). This biochemical state corresponds to a very low CDK activity state. Finally, we use an interphase (CSF-released) state, a later time point after Ca 2+ addition to the CSF extract, which corresponds to S phase, as embryonic cycles are devoid of defined gap phases, such as G1 [25] (Figure 1A) .
Addition of recombinant Xenopus PLK4 (rPLX4 WT ) induces de novo assembly of MTOCs in cycling extracts positive for g-tubulin [22] ( Figure S1A ) and other centriolar markers (Cep135, Centrin-1) ( Figure S1B ). Despite the similarity to centriole biogenesis, we never observed 9-fold symmetrical structures by electron microscopy (not shown), suggesting the lack of a limiting assembly factor.
To specifically inhibit PLK4's activity along the cell cycle, we generated an ATP-analog-sensitive recombinant PLX4 variant (also called a ''Shokat kinase'' [26] ), which can be specifically inhibited by ATP analogs. Previously, the substitution of a leucine residue by a glycine (L89G) in the ATP-binding pocket of hsPLK4 was reported to enhance the sensitivity to ATP analogs as desired [27] (Figure S2A ), albeit at the cost of a 10-fold reduction in activity in the absence of the ATP-analog inhibitor [27] (Figure S2B ). After testing several combinations, we determined that an L89A substitution combined with a compensatory mutation outside of the ATP-binding pocket (H188Y) [28] Figure 1B ;
Movie S1). The ATP analog 1-naphthyl-PP1 (1-NA-PP1) [29] was found to be a potent inhibitor of rPLX4 AS in vitro (Figures S2D and   S2E ; Movie S2), but not of rPLX4 WT (not shown).
Addition of rPLX4 AS to either M phase ( Figure 1C , i) or M exit extracts ( Figure 1C , ii) allowed MTOCs to form after M phase exit. Addition of rPLX4 AS in interphase itself (when the extract had completely exited M phase; ''CSF-released'') did not trigger MTOC formation ( Figure 1C , iii). To further investigate the timing, we added rPLX4 AS in M phase and inhibited by 1-NA-PP1 in M phase ( Figure 1D , iv) at the exit of M phase ( Figure 1D , v) or in interphase ( Figure 1D , vi). We only observed MTOC formation if rPLX4 AS was active at M exit, suggesting that it triggers de novo MTOC formation at a stage in which CDK activity is very low.
Centriole Duplication in Human Cells Requires Active PLK4 after Exit from Mitosis
To investigate whether a similar temporal requirement for PLK4 activity operates in the presence of centrioles and defined G1 and G2 phases, we generated a HeLa cell line conditionally expressing the human Shokat allele PLK4 AS (L89A/H188Y) (Figures S2A, S2B, and S2F). Cells were simultaneously depleted of endogenous PLK4 and induced to express RNAi-resistant PLK4 AS , which rescued the reduction in centriole number caused by depletion of endogenous wild-type PLK4 (Figure S2G) . Importantly, although 1-NA-PP1 treatment alone had no effect on centriole number or cell-cycle progression (not . Surprisingly, given that centrioles start being assembled in S phase, PLK4 inhibition during S phase or G2 had no major effect on the number of centrioles present in mitotic cells in the same cycle (Figures 2A and 2B ). We confirmed these findings using the recently described PLK4-specific inhibitor centrinone [30] . Only cells inhibited from mitosis onward of the previous cycle or from G1 of the same cycle showed a significant decrease in centriole-duplication efficiency ( Figure 2C ; Figure S2J), suggesting, again, that PLK4 acts in low CDK activity stages. In human cells, we could not perform controlled experiments of inhibition in mitosis followed by release of inhibition, as PLK4 catalyzes its own degradation [3] . Inhibited PLK4 accumulates, causing centriole overamplification upon inhibitor wash-off (previously shown in [30] ).
The PLK4-STIL Complex Only Forms upon M Exit
To understand the regulation of PLK4 activity in time, we focused on the first reported event of centriole biogenesis-the formation of the PLK4-STIL complex-and asked whether it occurs at M exit/G1. We first confirmed that STIL has a conserved role in MTOC formation in Xenopus extracts ( Figures S3A-S3D) . STIL is present, and its depletion precluded the formation of rPLX4-induced MTOCs ( Figures S3A-S3C ). Moreover, rPLX4
AS was able to bind and phosphorylate STIL ( Figure S3D ). Our results suggest a general, conserved mechanism in which STIL is phosphorylated by PLK4 and is required for rPLX4-induced MTOC formation, similar to what is described for human cells [7] [8] [9] [10] . Next, we observed that rPLX4 cannot bind STIL in M phase but only after M exit ( Figure 3A) , at which time it can also phosphorylate it (see shift of STIL band; Figure 3B ).
We then asked how PLK4-STIL complex formation is regulated in the presence of centrioles in human cells. We immunoprecipitated FLAG-PLK4 from HeLa cells synchronized in different cell-cycle stages preceding S phase onset: mitosis (M) and early (3 hr post-mitosis [PM]), mid (6 hr PM), and late (9 hr PM) G1 (Figures 3C-3E ; Figure S3E ). Even though both STIL and PLK4 concentrations are highest in mitosis ( Figures  3C-3E; Figures S3F, S4A , and S4B) [15, 16] , PLK4-STIL interaction was only observed during mid-and late G1 phases, 6 and 9 hr after mitotic exit, respectively ( Figure 3D ; Figure S3E ). PLK4 is detectable at the centrosome in those stages ( Figures  S4A and S4B ) and, consistently, the percentage of cells with STIL localizing to the centrosome increased significantly starting at mid-G1 ( Figure 3E ). This was followed by a significant increase of cells with SAS6 localizing to the centrosome in late G1 (9 hr PM; Figure S3G ). Importantly, cells treated with the PLK4 inhibitor centrinone for 1 hr prior to fixation showed a marked reduction in STIL and SAS6 presence at the centrosome in G1, but not in mitosis ( Figure 3E ; Figure S3G ). Our observations suggest that either the recruitment or the maintenance of STIL, and consequently of SAS6, at the centrosome in human cells is dependent on PLK4 activity during G1.
Taken together, our results show that despite the fact that both STIL and PLK4 are present at high CDK1-CyclinB activity states in both acentriolar Xenopus egg extracts and in human cells, the two proteins do not form a complex in either of the systems at these stages (Figure 3) , suggesting a conserved inhibitory mechanism related to CDK1-CyclinB activity.
Inhibiting CDK1-CyclinB Allows for PLK4-STIL Complex Assembly
We asked whether direct inhibition of CDK1 by the CDK1 inhibitor RO-3306 [31] would permit unscheduled complex formation. CDK1 inhibition in M phase released the extracts to interphase, and this was sufficient for rPLX4 to bind-and likely phosphorylate-STIL (see STIL mobility shift upon rPLX4 addition; Figures 4A and 4B) and to induce MTOC formation ( Figure 4C ). Likewise, acute inhibition of CDK1 activity in human cells blocked in mitosis restored the PLK4-STIL interaction ( Figure 4D ; Figure S4C ). Taken together, these results strongly corroborate an inhibitory function of CDK1 in PLK4-STIL complex assembly.
CDK1-CyclinB Phosphorylates and Binds to STIL CDK1-CyclinB prevents the initiation of DNA replication (i.e., licensing) both by phosphorylation of (i.e., Orc2) and binding to (i.e., Orc6) components that are required for this step [32, 33] . We thus asked whether CDK1-CyclinB could regulate PLK4-STIL complex assembly, by phosphorylating and/or binding to STIL. Given that STIL is highly phosphorylated in M phase (Figure S5A) and its localization at the centrosome is dependent on CDK1 activity [34] , we tested whether it is a substrate of CDK1-CyclinB. In vitro kinase assays showed incorporation of 32 P-radiolabeled ATP into STIL in the presence of either CDK1-CyclinB or PLX4 (positive control) ( Figures S5A and S5B) .
We then asked whether CDK1-CyclinB could phosphorylate and/or bind the domains/residues in STIL that normally bind/ are phosphorylated by PLK4, to prevent their interaction. PLK4 binds to STIL in the coiled-coil (CC) domain [7] [8] [9] [10] (Figure 5A ) and phosphorylates STIL on a domain known as the STAN motif, leading to SAS6 recruitment and cartwheel assembly [7] [8] [9] [10] . We used hemagglutinin (HA)-tagged full-length STIL (FL) and truncated STIL fragments previously described by Ohta and colleagues [7] (DCC, N-terminal domain [N] , and N3C; Figure 5A ) expressed in HEK293T cells as substrates in an in vitro kinase assay. Importantly, we showed that CDK1-CyclinB phosphorylates the N-terminal domain of STIL but not the region encompassing the CC or STAN motifs (Figures 5B and 5C ; confirmed with phospho-specific antibodies against a residue phosphorylated by PLK4 S1116 in the STAN domain [8] in Figure 5D ). Therefore, CDK1-CyclinB phosphorylates STIL, but on a physically distinct site from the one bound and phosphorylated by PLK4.
We then tested whether CDK1-CyclinB could bind STIL in vivo. We observed that indeed CDK1-CyclinB co-immunoprecipitates with STIL in Xenopus extracts arrested in M phase, but not after M exit when Cyclin B is degraded (Figures 6A and 6B) . Similarly, when treating M phase extracts with the CDK1 inhibitor RO-3306 in which the CDK1-CyclinB complex is inactive but Cyclin B is not degraded due to the natural absence of Cdh1, inactivated CDK1-CyclinB could not bind STIL ( Figure S5C1 ). Conversely, PLK4 binding to STIL was re-established ( Figure S5C2 ).
We then asked whether binding of CDK1-CyclinB to STIL would prevent STIL from interacting with PLK4. We performed CDK1-CyclinB immunoprecipitation from HEK293T cells expressing HA-tagged FL-STIL or the truncated fragments: DCC, which does not bind PLK4 [7] [8] [9] [10] , and an N-terminal domain. We found that whereas CDK1-CyclinB binds FL-STIL and N-STIL, it does not bind DCC-STIL (Figures 6A and 6C ). Despite this, DCC-STIL is phosphorylated by CDK1-CyclinB Figure S3E for more details. (E) STIL recruitment to the centrosome during mid-G1 phase is dependent on PLK4 activity. The presence of STIL at the centrosome was quantified by immunofluorescence using anti-STIL in mitotic or G1 cells obtained after mitotic shake-off. DMSO (control) or centrinone (PLK4 inhibitor) was added 1 hr prior to fixation. The absence of S phase cells in G1 was corroborated by EdU incorporation (n = 3; 100 cells/condition; mean ± SEM). See also Figures S3F, S3G , S4A, and S4B for more details of these experiments. ( Figure 5B), suggesting that in vitro phosphorylation and binding are not mutually dependent. More importantly, our results show that binding of CDK1-CyclinB to STIL requires the CC domain of STIL.
We then asked whether the CC domain is sufficient for CDK1-CyclinB binding. Immunoprecipitated CDK1 from HEK293T cells expressing GFP-CC [10] or GFP-FL STIL is able to efficiently bind both GFP-CC and GFP-FL (but not GFP alone) ( Figure 6D ). Our results demonstrate that the CC domain is both necessary and sufficient for CDK1-CyclinB binding to STIL.
CDK1-CyclinB Binds STIL, Preventing STIL-PLK4 Complex Formation and STIL Phosphorylation by PLK4
Our results raise the intriguing possibility that CDK1-CyclinB and PLK4 may compete for binding to STIL. We tested this hypothesis using a glutathione S-transferase (GST)-N3C-DSTAN-STIL fragment. Remarkably, we observed that although both proteins can interact separately with GST-N3C-DSTAN ( Figure 6E , I and II; Figure S6A ), initial incubation of this fragment with CDK1-CyclinB prevents PLX4 from binding to it (Figure 6E , III; Figure S6A ). Moreover, this assay was performed in the absence of ATP, reinforcing that binding and phosphorylation of STIL by CDK1-CyclinB might not be linked. Importantly, we observed that increasing concentrations of CDK1-CyclinB are able to physically displace a constant amount of PLK4 from binding STIL immunoprecipitated from Xenopus interphase extracts ( Figure S6B) .
Finally, we asked whether CDK1-CyclinB-STIL binding would also preclude STIL phosphorylation by PLK4 in the STAN motif, which is the critical event that recruits SAS6 [7, 8, 11] . We used FL-STIL and incubated it with PLK4 and CDK1-CyclinB individually or sequentially, and asked whether PLK4 can phosphorylate STIL in S1116 ( Figure 6F ). If PLK4 accesses STIL alone, or first, it is able to phosphorylate S1116 ( Figure 6F, III) . However, pre-incubation of CDK1-CyclinB precludes PLK4 phosphorylation ( Figure 6F, IV) . Previous reports indicated that PLK4 interaction with STIL enhances PLK4's activity [8] . Consistently, we observed that PLK4 autophosphorylation is reduced when its binding to STIL is disrupted by the presence of CDK1-CyclinB (see P PLK4 levels in Figure S6C , III versus IV). In summary, we
show that CDK1-CyclinB prevents STIL-PLK4 interaction by binding STIL in a kinase-independent fashion through the same region as PLK4. In turn, this prevents both the phosphorylation of STIL by PLK4 and further activation of PLK4. Given the low concentration of PLK4 in the cell [23] , it is likely that CDK1-CyclinB is able to prevent PLK4's binding to STIL in mitosis.
DISCUSSION
A critical ill-understood question in centriole biogenesis is how the cell-division and centriole-duplication cycles are coupled, so that centriole assembly occurs once and only once per cell cycle. Here we show how the first known biochemical event in centriole biogenesis, the association between PLK4 and its substrate STIL, is regulated during the cell cycle. We demonstrate that PLK4 activity is needed for centriole biogenesis before pro-centrioles become detectable in S phase. PLK4 binds and phosphorylates STIL in mid-G1. We show that the major mitotic kinase, CDK1-CyclinB, prevents precocious PLK4-STIL complex assembly and STIL phosphorylation in mitosis by binding to STIL in the same CC domain. These observations strongly support a model in which (1) in S phase and early G2, centriole reduplication is inhibited by centriole physical proximity; (2) in early mitosis, although centrioles overcome the critical distance that prevents reduplication [18] [19] [20] , and PLK4 and STIL levels are very high [15, 16] , CDK1-CyclinB prevents STIL from interacting with and being phosphorylated by PLK4, releasing it from the centriole [34] ; (3) after mitotic exit, following inactivation of CDK1, and new synthesis of STIL and PLK4 in mid-G1, PLK4 can bind and phosphorylate STIL [7] [8] [9] [10] 35] ; and (4) phosphorylated STIL recruits SAS6 [8, 9, 11] and new cartwheel formation starts at the G1/S boundary [12] . Our work provides a mechanistic link between cell-cycle progression and centrosome biogenesis and a rationale for the observation that centriole biogenesis can only start after exit from mitosis. Our model is supported by previous unexplained findings: inhibition of CDK1-CyclinB in Drosophila wing disc cells, Chinese hamster ovary cells, and chicken DT40 cells leads to unscheduled centriole formation [36, 37] . Moreover, previous work from our laboratory demonstrated that PLK4 overexpression can only drive de novo centriole biogenesis upon exit from meiosis in Drosophila eggs, suggesting that inhibition by CDK1-CyclinB in M phase could limit PLK4 activity in many contexts [21] . We note, however, that our model does not exclude additional roles of CDK1 in centriole biogenesis regulation through the activation or inhibition of additional regulators and/or substrates.
Remarkably, the results we present here can be paralleled to licensing mechanisms shown originally to operate in DNA replication and, more recently, centromere assembly (for a review of this topic, see [38] ) in certain aspects. In both cases, critical ''licensing'' events can only occur in G1. This is the loading of the helicase that unwinds the DNA onto the origins of replication, or the loading of the centromeric histone H3, CENP-A, to centromeres. CDK1 inactivates the licensing factor Cdt1 and binds to Orc6 [32, 33, 39] , and also prevents loading of CENP-A in different ways [40] . Therefore, both in the case of DNA replication and centromere assembly, CDK1 prevents untimely interactions, ensuring those events occur only once per cell cycle. Assembly of the PLK4-STIL complex in G1, separated from centriole assembly in S phase, can be thought of as a sort of licensing event for centriole duplication, ensuring it occurs ''once and only once'' per cell cycle. Additional layers of regulation, such as centriole proximity [17, 18] , clearly operate in addition to the mechanism we uncovered here to prevent unscheduled licensing in S and G2 phases. Our results raise several important questions for understanding how centriole numbers are controlled. Whereas binding of CDK1-CyclinB to STIL requires an active CDK1-CyclinB complex, it is not phosphorylation dependent ( Figure 6E ), giving rise to the intriguing possibility that phosphorylation and binding could regulate independent aspects of STIL's biology in the cell. Where is CDK1 binding STIL-is it in the cytoplasm or the centrosome pool? Furthermore, how are degradation of STIL by the APC/C in mitotic exit [15, 34] and translation dynamics of new protein pools in G1 fine-tuned? Understanding these will explain why critical events start in mid-G1 and not immediately after Cyclin B degradation. Finally, what role do CDK2-Cyclin complexes [41] [42] [43] [44] [45] play in regulating PLK4-STIL complex formation? Quantitative knowledge of the different pools of players, their affinity to each other, and the regulatory mechanisms will lead to a more cohesive understanding of the overarching principles governing the cell-cycle coordination of synchronously occurring cellular processes. . HA-tagged FL-hSTIL, DCC, N [7] , and GFP-CC [10] were expressed in HEK293T cells. GST-N3C (DSTAN) was generated in a previous study [7] . Protein expression was performed as described previously [7] .
Protein Detection
Cell lysis was performed in lysis buffer; 50-75 mg of protein was run on a 4%-15% TGX gel (Bio-Rad), transferred onto a nitrocellulose membrane, and blotted following standard protocols. Antibodies used for protein detection and immunofluorescence assays are specified in the Supplemental Experimental Procedures. Polyclonal anti-PLX4 was generated in this study.
Preparation of Xenopus Egg Extracts and MTOC Formation Assay CSF-arrested and interphase egg extracts were prepared as previously described [46] . Purified PLX4
AS was added to 20 ml of CSF extracts at 0.675 mM and released into interphase by calcium addition (20 mM CaCl 2 ). MTOCs were analyzed by using tetramethylrhodamine B isothiocyanate (TRITC)-labeled porcine tubulin (Cytoskeleton; TL590M, lot 017). . Thymidine (2 mM; 17 hr; supplemented with 10 mM EdU or BrdU [bromodeoxyuridine]) was used for S phase block; 100 ng/mL (12 hr) nocodazole or 2.5 mM monastrol (14 hr) was used for mitotic block. G1 time points were obtained by mitotic shake-off.
Immunoprecipitation and Kinase Assays
Immunoprecipitated STIL was washed with RIPA buffer, and co-precipitated proteins were separated on a 4%-15% TGX SDS-PAGE gel (Bio-Rad). Kinase reactions were performed in kinase buffer supplemented with ATPgS and myelin basic protein. Radioactive kinase reactions were performed in the presence of 1 mCi [g-32 P]ATP (replenishing ATP between kinases in the case of sequential incubations). For phosphorylation assays, GST-hSTIL (FL) [8] or immunoprecipitated STIL was incubated in kinase buffer supplemented with 500 ng of CDK1-CyclinB and/or 500 ng of PLK4. For sequential incubation, GST-N3C (DSTAN) was incubated in binding buffer containing 500 ng of CDK1-Cyclin, washed, subsequently incubated with 500 ng of GFP-PLX4, and eluted in Laemmli buffer. Assays were analyzed by Coomassie staining, autoradiography, or western blotting. For immunoprecipitation from human cells, 1-2 mg of total whole-cell lysate was incubated with protein G coupled to the appropriate antibody, washed, and eluted in Laemmli buffer.
Immunofluorescence Assays, Microscopy, and Flow Cytometry Analysis Staining with EdU was performed using the Click-iT EdU Alexa Fluor 647 imaging kit (Thermo Fisher Scientific). Propidium iodide or BrdU staining was analyzed on a BD FACScan flow cytometer. Data were plotted and analyzed using FlowJo (Tree Star). Images were collected on a DeltaVision microscope (Applied Precision) using softWoRx (Applied Precision) or a spinning disk CSU-X1 (Yokogawa) confocal scan head coupled to a Nikon Eclipse Ti-E and controlled using MetaMorph 7.5 (Molecular Devices). Prism (version 5.0c; GraphPad) was used for statistical analysis and plotting. 
